Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial.
- DOI
- 10.1001/jamaophthalmol.2025.0001
- Published
- 2025 Apr 1
- Container
- JAMA ophthalmology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1001/jamaophthalmol.2025.0001,
title = {Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial.},
author = {Pieramici DJ and Awh CC and Chang M and Emanuelli A and Holekamp NM and Hu AY and Suñer IJ and Wykoff CC and Brittain C and Howard D and Quezada-Ruiz C and Santhanakrishnan A and Latkany P},
year = {2025},
journal = {JAMA ophthalmology},
doi = {10.1001/jamaophthalmol.2025.0001},
url = {https://doi.org/10.1001/jamaophthalmol.2025.0001}
}RIS
TY - JOUR TI - Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial. AU - Pieramici DJ AU - Awh CC AU - Chang M AU - Emanuelli A AU - Holekamp NM AU - Hu AY AU - Suñer IJ AU - Wykoff CC AU - Brittain C AU - Howard D AU - Quezada-Ruiz C AU - Santhanakrishnan A AU - Latkany P PY - 2025 JO - JAMA ophthalmology DO - 10.1001/jamaophthalmol.2025.0001 UR - https://doi.org/10.1001/jamaophthalmol.2025.0001 ER -
APA
DJ, P., CC, A., M, C., A, E., NM, H., AY, H., IJ, S., CC, W., C, B., D, H., C, Q., A, S., & P, L. (2025). Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial.. JAMA ophthalmology. https://doi.org/10.1001/jamaophthalmol.2025.0001
Source records
- pubmed · retrieved 2026-09-27T08:18:37.896Z